AVAXZIPEN Canadian Trademark Information

On Friday, March 31, 2023, a canadian trademark registration was filed for AVAXZIPEN by AVAXZIPEN LIMITED *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 2309180. The current status of this trademark filing is Filing date accorded. The AVAXZIPEN trademark is filed in the description of Pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical use; biological, chemical and biochemical reagents for medical use; contraceptive preparations and substances. , Surgical, medical, dental and veterinary apparatus and instruments; drug delivery devices; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devices, namely drug cassettes excluding the drug; drug delivery devices, namely medical injectors, needle-free injectors, injectors with needles, all excluding he drug; drug delivery devices, including medical injectors, needle-free injectors and parts and fittings therefore; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug cassettes for use in drug delivery devices to contain pharmaceutical and biopharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; parts and fittings for all the aforesaid goods. , Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; pharmaceutical and biopharmaceutical delivery system development services; preparation and/or formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services; consultancy in relation to the aforesaid services. .